Skip to content

General Anxiety Disorder (GAD) Study

ITI-1284 as an Adjunctive Treatment in Patients with Generalized Anxiety Disorder (GAD)

The Michigan Clinical Research Institute is currently enrolling  those who have been diagnosed with GAD, and have received inadequate response from their current treatment. 

An individual may qualify for the study if they:

  • Are 18 years of age or older
  • Have been diagnosed with General Anxiety Disorder (GAD)
  • Have had no response or inadequate response from the current medications they are taking to treat this condition
  • Meet additional study criteria

Reimbursement for reasonable, out-of-pocket expenses such as travel and accommodations may be available to qualified individuals.

Contact us or fill out the form below so we can reach out to you and move forward with pre-screening questions to assess your overall eligibility. 

Interested in participating in a research study involving new medications?

  • Date Format: MM slash DD slash YYYY